The diagnosis and management of perniosis (chilblains)

South African Family Practice

Volumn 49, Issue 6, 2007, Pages 28-29

  Jordaan, H Francois ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; NICOTINAMIDE; NICOTINIC ACID HEXYL ESTER; NIFEDIPINE;

ACROCYANOSIS; ARTICLE; CLINICAL FEATURE; COLD EXPOSURE; COLD INJURY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG HALF LIFE; DRUG WITHDRAWAL; DYSPROTEINEMIA; ENVIRONMENTAL FACTOR; ERYTHROCYANOSIS; FLUSHING; HEADACHE; HUMAN; HYPOTENSION; PATHOGENESIS; PERIPHERAL EDEMA; SIDE EFFECT; SKIN BIOPSY; SYMPATHECTOMY; ULTRAVIOLET B RADIATION;

EID: 34548506048     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: 10.1080/20786204.2007.10873574     Document Type: Article

References (6)

1. St. Clair NE, Kim CC, Semrin G, et al. Celiac disease presenting with chilblains in an adolescent girl. Pediatr Dermatol 2006;23:451-454.
2. Weedon D. Skin Pathology.2nd. ed. St Louis, Mo: Churchill Livingstone Inc; 2002:250-251.
3. Weston WL, Morelli J. Childhood pernio and cryoproteins. Pediatr Dermatol 2000;17:97-99.
4. Viguier M, Pinquier L, Cavelier-Balloy B, et al. Clinical and histopathologic features and immunologic variables in patients with severe chilblains: a study of the relationship to lupus erythematosus. Medicine 2001;80:180-188.
5. Cribier B, Djeridi N, Peltre B, Grosshans E. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol 2001;45:924-929.
6. Rustin MHA, Newton JA, Smith NP, Dowd PM. The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol 1989;120:267-275.